Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Quality of Life in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Rajaram Nagarajan, MD MS, Todd A Alonzo, PhD, Robert B Gerbing, MA, Donna Johnston, MD FRCPC, Richard Aplenc, MD PhD, E. Anders Kolb, MD, Soheil Meshinchi, MD PhD, Lamia Barakat, PhD, Lillian Sung, MD PhD

Blood (2018) 132 (Supplement 1): 4841.

https://doi.org/10.1182/blood-2018-99-112152

Published: 2018

Journal Articles

High Vs. Low-Intensity Bridging Chemotherapy in Children with Acute Lymphoblastic Leukemia Awaiting Chimeric Antigen Receptor T-Cell Therapy: A Population-Based Study from Ontario, Canada

Sumit Gupta, MD, Sarah Alexander, MD, Sue Zupanec, RN, Uma Athale, MDMBBS,MSc, Mylene Bassal, MD, Ethan Edwards, Paul J. Gibson, MD, Donna Johnston, MDFRCPC, Stacey Marjerrison, MD, Alexander Zorzi, MD, Johann K. Hitzler, MD, Ahmed Naqvi, MD, Angela Punnett, MD, James A. Whitlock, MD, Stephan A. Grupp, MD PhD, Shannon L. Maude, MD PhD, Joerg Krueger, MD

Blood (2018) 132 (Supplement 1): 1410.

https://doi.org/10.1182/blood-2018-99-115593

Published: 2018

Journal Articles

Outcomes Based on CNS Disease Status in Pediatric Acute Myeloid Leukemia and the Role of Peripheral Blood Contamination in Diagnostic Lumbar Punctures; A Report from the Children's Oncology Group Studies AAML0531 and AAML1031

Matthew A. Kutny, MD, Todd A Alonzo, PhD, Robert B Gerbing, Yi-Cheng Wang, Richard Aplenc, MD, Alan S Gamis, MD MPH, James Feusner, William G. Woods, MD, Soheil Meshinchi, MD PhD, Donna Johnston, MDFRCPC

Blood (2017) 130 (Supplement 1): 3859.

https://doi.org/10.1182/blood.V130.Suppl_1.3859.3859

Published: 2017

Journal Articles

Clinical Impact of Additional Cytogenetic Aberrations, cKIT- and RAS Mutations and Other Factors in Pediatric t(8;21)-AML

Blood (2014) 124 (21): 481.

https://doi.org/10.1182/blood.V124.21.481.481

Published: 2014

Journal Articles

Pediatric Oncology Clinic Care Model: How to Care for Patients to Achieve Better Continuity of Care in a Medium Sized Program

Donna Johnston, MD FRCPC, Jacqueline Halton, MD, Mylene Bassal, MD, Robert J. Klaassen, MD FRCP, Karen Mandel, MD, Raveena Ramphal, MD, Ewurabena Simpson, MD MPH, Li Peckan

Blood (2014) 124 (21): 6000.

https://doi.org/10.1182/blood.V124.21.6000.6000

Published: 2014

Journal Articles

An Analysis of CNS2 Patients with AML: Do They Require Additional Intrathecal Therapy? a Report from Children’s Oncology Group Protocols AAML0531 and 03P1 and St Jude Children’s Research Hospital Protocol AML02

Donna Johnston, MD FRCPC, Jeffrey E Rubnitz, MD PhD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Richard Aplenc, MD PhD, Alan S. Gamis, MD MPH, Soheil Meshinchi, MD PhD

Blood (2014) 124 (21): 277.

https://doi.org/10.1182/blood.V124.21.277.277

Published: 2014

Journal Articles

Second Bacteremia During Antibiotic Treatment In Children With Acute Myeloid Leukemia: A Report From The Canadian Infections In AML Research Group

Thai Hoa Tran, Rochelle Yanofsky, MD, FRCP(C), Donna Johnston, MD, FRCPC, David Dix, MD, Biljana Gillmeister, Marie-Chantal Ethier, BSc, Carol Portwine, Victoria E. Price, MBChB, MD, David Mitchell, Sonia Cellot, MD, Victor A. Lewis, MD, Shayna Zelcer, MD, Mariana Silva, MD, Bruno Michon, MD, FRCPC, Lynette Bowes, MD, Kent Stobart, MD, MSC, Josee Brossard, MD, Joseph Beyene, PhD, Lillian Sung, MD, PhD

Blood (2013) 122 (21): 1415.

https://doi.org/10.1182/blood.V122.21.1415.1415

Published: 2013

Journal Articles

Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Münster AML-study group

Blood (2013) 122 (15): 2704–2713.

https://doi.org/10.1182/blood-2013-02-485524

Published: 2013

Includes: Supplemental data

Journal Articles

Pediatric Acute Myeloid Leukemia with t(8;16)(p11;p13): A Distinct Clinical and Biological Entity. Results of a Collaborative Study by the International Berlin-Frankfurt-Münster AML Study Group.

Blood (2012) 120 (21): 2516.

https://doi.org/10.1182/blood.V120.21.2516.2516

Published: 2012

Journal Articles

Clinical Impact of Additional Cytogenetic Aberrations and Treatment in Pediatric t(8;21)-Positive AML: Results from an International Retrospective I-BFM-SG Study

Blood (2012) 120 (21): 884.

https://doi.org/10.1182/blood.V120.21.884.884

Published: 2012

Journal Articles

Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel

Blood (2012) 120 (16): 3187–3205.

https://doi.org/10.1182/blood-2012-03-362608

Published: 2012

Includes: Supplemental data

Journal Articles

Volume of Cerebrospinal Fluid Removal Prior to Intrathecal Chemotherapy Administration: A Survey of Canadian Hematology/Oncology Practitioners,

Michaela Cada, MD, FRCPC, Donna Johnston, MD, FRCPC

Blood (2011) 118 (21): 4196.

https://doi.org/10.1182/blood.V118.21.4196.4196

Published: 2011

Journal Articles

Neutropenia In Infants with Hemolytic Disease of the Newborn.

Esther Blanco-Alemany, MD, Donna Johnston, MD, FRCPC

Blood (2010) 116 (21): 3794.

https://doi.org/10.1182/blood.V116.21.3794.3794

Published: 2010

Journal Articles

Pediatric Patients with Extramedullary Leukemia Involving the Central Nervous System Have a Superior Outcome.

Donna Johnston, MD, FRCPC, Todd Alonzo, PhD, Robert Gerbing, Beverly Lange, MD, William G. Woods, MD

Blood (2008) 112 (11): 920.

https://doi.org/10.1182/blood.V112.11.920.920

Published: 2008

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Quality of Life in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

High Vs. Low-Intensity Bridging Chemotherapy in Children with Acute Lymphoblastic Leukemia Awaiting Chimeric Antigen Receptor T-Cell Therapy: A Population-Based Study from Ontario, Canada

Outcomes Based on CNS Disease Status in Pediatric Acute Myeloid Leukemia and the Role of Peripheral Blood Contamination in Diagnostic Lumbar Punctures; A Report from the Children's Oncology Group Studies AAML0531 and AAML1031

Clinical Impact of Additional Cytogenetic Aberrations, cKIT- and RAS Mutations and Other Factors in Pediatric t(8;21)-AML

Pediatric Oncology Clinic Care Model: How to Care for Patients to Achieve Better Continuity of Care in a Medium Sized Program

An Analysis of CNS2 Patients with AML: Do They Require Additional Intrathecal Therapy? a Report from Children’s Oncology Group Protocols AAML0531 and 03P1 and St Jude Children’s Research Hospital Protocol AML02

Second Bacteremia During Antibiotic Treatment In Children With Acute Myeloid Leukemia: A Report From The Canadian Infections In AML Research Group

Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Münster AML-study group

Pediatric Acute Myeloid Leukemia with t(8;16)(p11;p13): A Distinct Clinical and Biological Entity. Results of a Collaborative Study by the International Berlin-Frankfurt-Münster AML Study Group.

Clinical Impact of Additional Cytogenetic Aberrations and Treatment in Pediatric t(8;21)-Positive AML: Results from an International Retrospective I-BFM-SG Study

Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel

Volume of Cerebrospinal Fluid Removal Prior to Intrathecal Chemotherapy Administration: A Survey of Canadian Hematology/Oncology Practitioners,

Neutropenia In Infants with Hemolytic Disease of the Newborn.

Pediatric Patients with Extramedullary Leukemia Involving the Central Nervous System Have a Superior Outcome.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only